比伐卢定在心脏手术中抗凝治疗的系统综述数据

包含比伐卢定在心脏手术中抗凝治疗的系统综述表格数据,覆盖19项研究的研究特征、偏倚风险和亚组结果。

figsharefigshare
DataCite Commons
2025-09-07 更新
浏览 20
表格Bivalirudinheparin-induced thrombocytopeniacardiopulmonary bypasscardiac surgeryanticoagulationbleedingthromboembolic eventsmeta-analysis
Detailed study characteristics, risk-of-bias tables, subgroup results

基本信息

模态
表格
大小
0.001538246 GB
许可
CC0
创建/更新时间
2025-09-07
版本
v1

资源简介

比伐卢定在心脏手术中抗凝治疗的系统综述数据

【一句话概览】

本数据集是 figshare 公开的结构化表格数据集,收录 1 个文件、合计 1.54 MB,主题涵盖 Bivalirudin、heparin-induced thrombocytopenia、cardiopulmonary bypass、cardiac surgery、anticoagulation,可用于统计建模、特征工程与队列分析,CC0 许可开放获取。

【数据集背景】

本数据集源站标题为《Detailed study characteristics, risk-of-bias tables, subgroup results》。项目资助方:The author(s) declare that no financial support was received from any organization for the submitted work.。源站首次发布:2025-09-07。

【数据内容】

源站原始描述:From 152 records screened, 19 studies were included: three cohort studies (170 patients) and 16 case reports/small series. - Cohort studies: - - Standardized bivalirudin protocols (bolus 1.0–1.2 mg/kg, infusion 2.0–2.7 mg/kg/h, ACT ≈480 s) were effective. - Major bleeding: pooled incidence 10.6% (95% CI: 6.4–16.9%). - Thromboembolic events: pooled incidence 2.1% (95% CI: 0.4–4.8%). - Early mortality: ≤3%. - No CPB circuit thrombosis or oxygenator exchanges were required. - Around 14% of patients…

【数据结构与技术规格】

文件数 1 个,合计 1.54 MB。Detailed study characteristics.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,1.54 MB。数据集 DOI:10.6084/m9.figshare.30070159.v1。

【主题与分类】

源站学科分类:Cardiology (incl. cardiovascular diseases)、Cardiovascular medicine and haematology not elsewhere classified、Haematology、Respiratory diseases。主题标签:Bivalirudin、heparin-induced thrombocytopenia、cardiopulmonary bypass、cardiac surgery、anticoagulation、bleeding、thromboembolic events、meta-analysis。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面:https://figshare.com/articles/dataset/_b_Detailed_study_characteristics_risk-of-bias_tables_subgroup_results_b_/30070159

使用许可:CC0(https://creativecommons.org/publicdomain/zero/1.0/)。

规范引用:KHALLIKANE, Said; BOUHABBA, Najib; BELGHITI, Amine; DIDI, Medi; BALLOUK, Ramiz; CHLOUCHI, Abdellatif; et al. (2025). Detailed study characteristics, risk-of-bias tables, subgroup results. figshare. Dataset

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付,我们提供全链路闭环服务,让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持?联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务(收技术服务费,非数据销售)

暂未开放

当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取(Figshare)

命令行下载

curl -L -o "Detailed study characteristics.docx" "https://ndownloader.figshare.com/files/57730444"

文件清单

  • Detailed study characteristics.docx(1.54 MB)

文件总体积 1.54 MB(源站 API 实测)。

数据加载示例(图像类)

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

From 152 records screened, 19 studies were included: three cohort studies (170 patients) and 16 case reports/small series.

  • Cohort studies:

    • Standardized bivalirudin protocols (bolus 1.0–1.2 mg/kg, infusion 2.0–2.7 mg/kg/h, ACT ≈480 s) were effective.
  • Major bleeding: pooled incidence 10.6% (95% CI: 6.4–16.9%).

  • Thromboembolic events: pooled incidence 2.1% (95% CI: 0.4–4.8%).

  • Early mortality: ≤3%.

  • No CPB circuit thrombosis or oxygenator exchanges were required.

  • Around 14% of patients needed dose adjustments due to ACT variability.

  • Case reports/series:

    • Showed feasibility in high-risk settings (emergent surgery, transplantation, pediatrics, renal failure, redo sternotomy).
  • ACT-guided protocols maintained circuit integrity, with no perioperative deaths or circuit failures.

  • Some cases required modified monitoring (e.g., plasma-modified ACT in thrombocytopenia, dose reduction in pediatrics).

  • Secondary outcomes:

    • Reoperation for bleeding: 5.3%.
  • Transfusion needs were variable but not excessive.

  • ICU stay: 2–4 days; hospital stay: 7–10 days.

  • No ECMO or mechanical circulatory support was required.

许可

CC0

引用

学术使用请引用 DOI 10.6084/m9.figshare.30070159.v1(source: https://figshare.com/articles/dataset/_b_Detailed_study_characteristics_risk-of-bias_tables_subgroup_results_b_/30070159)。

数据缺失?

依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。

⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。

获取专属数据定制方案